Phocas Financial Corp.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1356783 ALAMEDA, CA

Position in SUPN

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$3,277,817

-$763,787 QoQ

Shares Held

63,413

-22.0% QoQ

Ownership

0.109%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 16.30422783971741.ToString("F0")% Shared 0.ToString("F0")% None 83.69577216028259.ToString("F0")%

Healthcare · as of Mar 31, 2026

Phocas Financial Corp. holds $23,598,730 across 5 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (13.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	1,002,664	$12,463,113
2	ELAN	Elanco Animal Health Inc	142,521	$3,410,527
3	SUPN	Supernus Pharmaceuticals, Inc. This page	63,413	$3,277,817
4	PCRX	Pacira BioSciences, Inc.	114,413	$2,585,733
5	BCRX	Biocryst Pharmaceuticals Inc	195,540	$1,861,540

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,277,817	63,413	-22.0%	Shares	Sole	2026-05-01
2025-12-31	$4,041,604	81,320	-20.7%	Shares	Sole	2026-01-26
2025-03-31	$3,358,512	102,550	-5.5%	Shares	Sole	2025-05-09
2024-12-31	$3,922,600	108,479	-0.9%	Shares	Sole	2025-03-05
2024-09-30	$3,412,962	109,460	-5.9%	Shares	Sole	2024-11-07
2024-06-30	$3,112,175	116,343	-1.9%	Shares	Sole	2024-07-24
2024-03-31	$4,043,467	118,542	-2.5%	Shares	Sole	2024-05-01
2023-12-31	$3,517,917	121,559	-22.6%	Shares	Sole	2024-01-30
2023-09-30	$4,330,309	157,066	-0.1%	Shares	Sole	2023-10-10
2023-06-30	$4,725,912	157,216	-0.6%	Shares	Sole	2023-07-13
2023-03-31	$5,727,745	158,094	-9.6%	Shares	Sole	2023-04-13
2022-12-31	$6,240,323	174,946	+31.9%	Shares	Sole	2023-01-11
2022-09-30	$4,488,442	132,598	+25.0%	Shares	Sole	2022-10-14
2022-06-30	$3,068,556	106,105	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.